24小时热门版块排行榜    

查看: 982  |  回复: 4

xbqewpq

荣誉版主 (著名写手)

魂兮

[求助] 氟马西尼注射液进口标准

RT,求助氟马西尼注射液进口标准,原料和注射液的都想要,有木有啊?
回复此楼
红颜远,相思苦,几番意,难相付。十年情思百年渡,不斩相思不忍顾!
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

yugijiang

木虫 (著名写手)

【答案】应助回帖

★ ★ ★ ★ ★ ★ ★
感谢参与,应助指数 +1
xbqewpq: 金币+5, 有帮助 2012-08-04 21:41:03
soundhorizo: 金币+2, 专家辛苦 周末愉快 ^^ 2012-08-05 00:15:13
British Pharmacopoeia Volume I & II
Monographs: Medicinal and Pharmaceutical Substances
Flumazenil  
General Notices

(Ph. Eur. monograph 1326)





C15H14FN3O3    303.3    78755-81-4

Action and use
Benzodiazepine receptor antagonist.

Ph Eur

DEFINITION
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate.

Content
99.0 per cent to 101.0 per cent (dried substance).

CHARACTERS
Appearance
White or almost white, crystalline powder.

Solubility
Very slightly soluble in water, freely soluble in methylene chloride, sparingly soluble in methanol.

mp
198 °C to 202 °C.

IDENTIFICATION
Infrared absorption spectrophotometry (2.2.24).

Comparison  Ph. Eur. reference spectrum of flumazenil.

TESTS
Appearance of solution
The solution is clear (2.2.1) and is not more intensely coloured than reference solution BY7 (2.2.2, Method II).

Dissolve 0.10 g in methanol R and dilute to 10 mL with the same solvent.

Impurity C
Maximum 1 per cent.

Dissolve 0.10 g in 0.5 mL of methylene chloride R and dilute to 10 mL with butanol R. To 5.0 mL of this solution add 2.0 mL of ninhydrin solution R and heat in a water-bath at 95 °C for 15 min. Any blue-purple colour in the solution is not more intense than that in a standard prepared at the same time and in the same manner using 5.0 mL of a 0.1 g/L solution of dimethylformamide diethylacetal R in butanol R.

Related substances
Liquid chromatography (2.2.29).

Test solution  Dissolve 50.0 mg of the substance to be examined in 5 mL of methanol R and dilute to 25.0 mL with the mobile phase.

Reference solution (a)  Dissolve 2.0 mg of flumazenil impurity B CRS and 2.0 mg of the substance to be examined in the mobile phase and dilute to 25.0 mL with the mobile phase. Dilute 2.0 mL of this solution to 25.0 mL with the mobile phase.

Reference solution (b)  Dilute 10.0 mL of the test solution to 100.0 mL with the mobile phase. Dilute 1.0 mL of this solution to 100.0 mL with the mobile phase.

Column:
— size: l = 0.25 m, Ø = 4.6 mm,
— stationary phase: end-capped octadecylsilyl silica gel for chromatography R (5 µm).
Mobile phase  To 800 mL of water R adjusted to pH 2.0 with phosphoric acid R, add 130 mL of methanol R and 70 mL of tetrahydrofuran R and mix.

Flow rate  1 mL/min.

Detection  Spectrophotometer at 230 nm.

Injection  20 µL.

Run time  3 times the retention time of flumazenil.

Relative retention  With reference to flumazenil (retention time = about 14 min): impurity A = about 0.4; impurity D = about 0.5; impurity E = about 0.6; impurity B = about 0.7; impurity F = about 2.4.

System suitability  Reference solution (a):

— resolution: minimum 3.0 between the peaks due to impurity B and flumazenil.
Limits:
— impurity B: not more than twice the area of the principal peak in the chromatogram obtained with reference solution (b) (0.2 per cent),
— unspecified impurities: for each impurity, not more than the area of the principal peak in the chromatogram obtained with reference solution (b) (0.10 per cent),
— total: not more than twice the area of the principal peak in the chromatogram obtained with reference solution (b) (0.2 per cent),
— disregard limit: 0.5 times the area of the principal peak in the chromatogram obtained with reference solution (b) (0.05 per cent).
Loss on drying (2.2.32)
Maximum 0.5 per cent, determined on 1.000 g by drying in an oven at 105 °C.

Sulfated ash (2.4.14)
Maximum 0.1 per cent, determined on 1.0 g in a platinum crucible.

ASSAY
Dissolve 0.250 g in 50 mL of a mixture of 2 volumes of acetic anhydride R and 3 volumes of anhydrous acetic acid R. Titrate with 0.1 M perchloric acid, determining the end-point potentiometrically (2.2.20).

1 mL of 0.1 M perchloric acid is equivalent to 30.33 mg of C15H14FN3O3.

IMPURITIES
Specified impurities  B, C.

Other detectable impurities (the following substances would, if present at a sufficient level, be detected by one or other of the tests in the monograph. They are limited by the general acceptance criterion for other/unspecified impurities and/or by the general monograph Substances for pharmaceutical use (2034). It is therefore not necessary to identify these impurities for demonstration of compliance. See also 5.10. Control of impurities in substances for pharmaceutical use): A, D, E, F.





A. R = H, R′ = F: 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid,

B. R = C2-H5, R′ = OH: ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate,

E. R = C2H5, R′ = H: ethyl 5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate,

F. R = C2H5, R′ = Cl: ethyl 8-chloro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate,





C. diethoxy-N,N-dimethylmethanamine,





D. 7-fluoro-4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione.
2楼2012-08-04 14:15:41
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

xbqewpq

荣誉版主 (著名写手)

魂兮

引用回帖:
2楼: Originally posted by yugijiang at 2012-08-04 14:15:41
British Pharmacopoeia Volume I & II
Monographs: Medicinal and Pharmaceutical Substances
Flumazenil  
General Notices

(Ph. Eur. monograph 1326)





C15H14FN3O3    303.3    78755-81-4
...

想要进口标准啊
红颜远,相思苦,几番意,难相付。十年情思百年渡,不斩相思不忍顾!
3楼2012-08-04 21:40:47
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

ll9999

专家顾问 (文坛精英)

优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主

【答案】应助回帖

感谢参与,应助指数 +1
一般是可以找FSDA的药典委员会要,只要不是保护期内,药典会给你的。
4楼2012-08-05 00:23:39
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

痴夷子皮

版主 (文坛精英)

老痞

优秀版主优秀版主

【答案】应助回帖

★ ★ ★ ★ ★
soundhorizo: 金币+5, 应助指数+1, 应楼主要求 感谢应助 2012-08-06 09:14:07
进口注册标准,一般网上很少有免费,建议找标准贩子RMB购买。论坛上有不少标准贩子。
守候在风中的宁静。
5楼2012-08-06 08:31:29
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 xbqewpq 的主题更新
信息提示
请填处理意见